InsuletPODD

NASDAQ · USA · Segment 1 of 8 in the Medicine, pharma & life science value chain: Diabetes & metabolic disease

American medtech company known for Omnipod — a tubeless insulin pump for diabetes management.

Diabetes & metabolic disease: Treatment and monitoring of diabetes and metabolic disease — from insulin to glucose monitoring.

Key metrics

Market cap

$11.1B

Price

$161.21

Today

+1.8%

Return YTD

−44.3%

Return 1Y

−46.8%

P/E

36.6

P/S

3.8

P/B

7.3

Data as of 2026-07-10 · updates daily after U.S. close

Theme exposure

DiabetesInsulin pumpsMedtech exposureInsulin deliveryDigital health

In the value chain

Products & services

Omnipod insulin pump
Automated insulin dosing

Competitors

Medtronic Diabetes
Tandem
DexCom (CGM)

Risks

Competition
Reimbursement changes

Same segment: Diabetes & metabolic disease

Eli LillyLLY DexComDXCM

See where Insulet sits in the full Medicine, pharma & life science map — every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →